We are currently carrying out work to improve the usability of our search function. This may cause search results to be incomplete. We anticipate this issue will be resolved in the coming hours.
Filter by
Past events (3078)
European Medicines Agency, Amsterdam, the Netherlands
Start date:
1 February 2024, 15:30 (CET)
End date:
1 February 2024, 17:00 (CET)
EventHumanMedicines
EudraVigilance is the EU's system for managing and analysing information on adverse reactions to medicines which have been authorised or are being studied in clinical trials in the European Economic Area (EEA) and supports the reporting and analysis of suspected adverse reactions originating from clinical trials and the post-authorisation phase of...
Online
Start date:
29 January 2024
End date:
2 February 2024
Event
European Medicines Agency, Amsterdam, the Netherlands
Start date:
29 January 2024
End date:
29 January 2024
EventHumanVeterinaryMedicine shortages
European Medicines Agency, Amsterdam, the Netherlands
Start date:
29 January 2024
End date:
31 January 2024
EventHerbalMedicines
Online
Start date:
29 January 2024
End date:
29 January 2024
EventHumanMedicines
Online
European Medicines Agency, Amsterdam, the Netherlands
Start date:
25 January 2024, 13:00 (CET)
End date:
26 January 2024, 13:00 (CET)
EventHumanClinical trials
Online
European Medicines Agency, Amsterdam, the Netherlands
Start date:
24 January 2024, 16:00 (CET)
End date:
24 January 2024, 17:00 (CET)
EventHumanClinical trialsRegulatory and procedural guidance
Online
Start date:
22 January 2024, 10:00 (CET)
End date:
22 January 2024, 13:30 (CET)
EventHumanMedicine shortages
The Committee for Medicinal Products for Human Use (CHMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning human medicines.
European Medicines Agency, Amsterdam, the Netherlands
Start date:
22 January 2024
End date:
25 January 2024
EventHumanMedicines
The Committee for Advanced Therapies (CAT) is the committee that is responsible for assessing the quality, safety and efficacy of advanced-therapy medicines.
European Medicines Agency, Amsterdam, the Netherlands
Start date:
17 January 2024
End date:
19 January 2024
EventHumanAdvanced therapiesInnovation